Cannabis
Cicatrix Labs Announces Launch of Assuage Brand Suppositories to the Canadian Market
Kelowna, British Columbia–(Newsfile Corp. – February 14, 2022) – Cicatrix Labs Ltd, a holder of a cannabis processing license under the Cannabis Act, announces the launch of a line of cannabis suppositories through a partnership with VIVO Cannabis Inc (TSX: VIVO) (OTCQX: VVCIF) and its wholly-owned subsidiaries Canna Farms Limited and ABcann Medicinals Inc. These vaginal and rectal suppositories will be available on VIVO’s Canna Farms e-commerce marketplace.
“This product launch is the first step in our mission of bringing uniquely effective cannabis products to the Canadian market. We have invested heavily in product safety and, unlike current illegal cannabis suppository sources, our suppositories are tested for pesticides, heavy metals and bacterial and fungal contamination,” said Sarah Roberts, a pharmacist and Founder and President of Cicatrix Labs. “Choice is important to our customers and physicians. Not everyone is well served by the products currently available and suppositories offer an important alternative for women’s health and gastrointestinal conditions. With their strong history of patient care, Canna Farms was the logical partner.”
Assuage™ suppositories for vaginal or rectal use are available in two strengths: 50mg cannabidiol (CBD) and a 1:3 formulation with 10mg tetrahydrocannabinol (THC) plus 30mg CBD.
“VIVO continues to advance our focused medical strategy and to ensure that our patients have access to the best cannabis products available, including novel cannabinoid-based formulations,” commented Ray Laflamme, Canna Farms’ Co-Founder and VIVO’s Chief Executive Officer. “We are extremely proud to be the first medical marketplace in Canada to launch the broadest range of suppositories available to all Canadian patients.”
These newly launched Assuage™ vaginal and rectal suppositories are available through the Canna Farms e-commerce medical marketplace for Canadian medical clients. Patients requiring support with registration or order placement can contact VIVO’s Customer Care Team at 1 (855) 882-0988 or [email protected].
Assuage Brand Cannabis Suppositories Launch to Canadian Market
To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/8595/113565_10796f4ed48ccb88_002full.jpg
About Cicatrix Labs
Cicatrix Labs is a pharmacist-founded manufacturer of unique cannabinoid-infused products including topicals and suppositories. Cicatrix Labs offers an in-house line of personal care products to Licensed Producers and Medical License holders as well as custom white labeled products. For more information visit: www.cicatrixlabs.ca
About VIVO Cannabis™
VIVO Cannabis™ is recognized for trusted, premium cannabis products and services. It holds production and sales licenses from Health Canada and operates world-class cultivation facilities. For more information visit: www.vivocannabis.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/113565
Cannabis
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
Cannabis
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
Cannabis
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
transfer1 week ago
IMC to transfer its Oranim Pharmacy shares back to the seller
-
Cannabis6 days ago
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
-
Cannabis1 week ago
Right on Brands Announces Major Product Line Expansion via HONEY® Brands
-
Cannabis1 week ago
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
CCELL®1 week ago
CCELL Launches Environmentally Conscious Eco Star AIO Vaporizer
-
Innocan3 days ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf3 days ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis3 days ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care